ARMAGEN, INC.

Profile

Company Names

ARMAGEN, INC.
ARMAGEN TECHNOLOGIES INC

Addresses

26679 AGOURA ROAD, SUITE 100, CALABASAS, CA 91302

914 COLORADO AVE, SANTA MONICA, CA 90401

Phone Numbers

818-252-8215
3109171275

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY, PHARMACEUTICALS

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$18,492,898.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2018-02-23 
$9,999,999.00 
$9,999,999.00 
$0.00 
Equity 
1
2012-11-13 
$8,492,899.00 
$16,985,828.00 
$8,492,929.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
RUBEN 
 
BOADO 
EXECUTIVE OFFICER
ARMAGEN, INC.
RUBEN 
J. 
BOADO 
EXECUTIVE OFFICER
ARMAGEN TECHNOLOGIES INC
MARTIN 
 
HEIDECKER 
DIRECTOR
ARMAGEN TECHNOLOGIES INC   |  SENTIEN BIOTECHNOLOGIES, INC.   |  TILOS THERAPEUTICS, INC.   |  ABEXXA BIOLOGICS, INC.   |  ARMAGEN, INC.   |  RGENTA THERAPEUTICS, INC.   |  VENATORX PHARMACEUTICALS, INC.   |  VEDANTA BIOSCIENCES, INC.   |  ADAPTIVE PHAGE THERAPEUTICS, INC.   |  ELION THERAPEUTICS, INC.
WILLIAM 
 
PARDRIDGE 
EXECUTIVE OFFICER, DIRECTOR
ARMAGEN TECHNOLOGIES INC   |  ARMAGEN, INC.
JAYSON 
 
PUNWANI 
DIRECTOR
ARMAGEN, INC.   |  VELOSBIO INC.   |  ADDITION THERAPEUTICS, INC.
MATHIAS 
 
SCHMIDT 
EXECUTIVE OFFICER, DIRECTOR
ARMAGEN, INC.
STUART 
 
SWIEDLER 
DIRECTOR
ARMAGEN TECHNOLOGIES INC
ARTHUR 
 
TZIANABOS 
DIRECTOR
ARMAGEN TECHNOLOGIES INC   |  HOMOLOGY MEDICINES, INC.   |  AKOUOS, INC.   |  STOKE THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2018-03-02
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-02-23 
2012-11-27
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2012-11-13 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#